S1P receptor modulators for treating relasping-remitting multiple sclerosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9187405
APP PUB NO 20140228446A1
SERIAL NO

14257342

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates uses of an S1P receptor modulator such as 2-substituted 2-amino-propane-1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising a group of formula X

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS PHARMACEUTICALS CORPORATIONONE HEALTH PLAZA EAST HANOVER NJ 07936

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hiestand, Peter C Austria, CH 7 7
Schnell, Christian Hesingue, FR 11 86

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00